ShobaAlaska(Reddy-Holdcraft)NavaiMD
Pediatric Hematology & Oncology • Houston, TXAssistant Professor of Pediatrics, Baylor College of Medicine
Dr. Navai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1102 Bates Ave
Ste 1770
Houston, TX 77030Phone+1 832-822-4242
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2014 - 2017- Baylor College of Medicine (Houston)Residency, Pediatrics, 2010 - 2014
Medical College of Georgia at Augusta UniversityClass of 2010
Certifications & Licensure
TX State Medical License 2012 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors Start of enrollment: 2023 Apr 18
Roles: Principal Investigator, Contact
- HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma Start of enrollment: 2021 Dec 07
- T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors Start of enrollment: 2016 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- National virtual tumor boards to inform the management of children with rare cancers.Shoba A Navai, Priya Mahajan, Rajkumar Venkatramani
Current Opinion in Pediatrics. 2025-02-01 - 1 citationsProlonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.Anne Miller, Rachel Daum, Tao Wang, Mengfen Wu, Candise Tat
Cytotherapy. 2024-09-01 - 8 citationsAutologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, Sujith K Joseph, Khaled Sanber
Nature Cancer. 2024-06-01
Press Mentions
The Faris Foundation Grant Funds Research for Advanced Sarcoma Clinical TrialDecember 4th, 2020
CAR T-cell Therapy for Mesothelioma Proving Effective in Clinical TrialApril 11th, 2019
Immune System Therapy Shows Wider Promise Against CancerApril 1st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
